Siren »

Black Diamond Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Siren from 13F filings

Historical chart of Siren investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.6M 1.0M 4.35

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Bellevue Group
Vestal Point Capital
NEA Management Company
BlackRock
BlackRock
Vanguard Group
Ikarian Capital
Tang Capital Management
Siren
Geode Capital Management
ExodusPoint Capital Management
Citadel Advisors
Kennedy Capital Management
Point72 Asset Management

View all funds holding Black Diamond Therapeutics